PainChek® enters home care market through pain management collaboration with MPS Connect
HIGHLIGHTS
• PainChek enters the Australian Home Care market, establishing an integrated pain management solution with Sigma Healthcare subsidiary MPS Connect
• The integrated PainChek® Universal Solution to be launched Q1 2022 within MPS Connect’s MediSphere™ Medication Management System
• MPS Connect currently services over 800 preferred pharmacy clients and 1400 Residential Aged care facilities in Australia
PainChek® Ltd (ASX: PCK) (“PainChek®” or “the Company”, developer of the world’s first smart phone-based pain assessment and monitoring application, is pleased to announce that is has entered the Australian Home Care market, establishing an integrated pain management solution with MPS Connect, a leading Australian medication services company.
The companies have collaborated to integrate the PainChek® Universal Solution into the soon to be launched MediSphere™ Medication Management System. The system combines pain assessment and pain treatment into one novel software system. The goal is to ensure the right medication is delivered, based on accurate pain assessment, for people living at home with home care packages.
This collaboration will bring together the pain medication expertise of MPS Connect (a subsidiary of Sigma Healthcare) and the pain assessment device from PainChek to monitor the effect of the intervention, creating a unique pain treatment and monitoring programme for people living at home.
In the agreement the PainChek™ Universal App is fully integrated into the MPS Connect MediSphere™ system to enhance the user experience and health outcomes for residents, nurses and patients. MPS Connect currently services over 800 preferred pharmacy clients and 1400 Residential Aged care facilities.
There are over 235,000 Federal Government funded Home Care packages in Australia, the majority of which are managed by Residential Aged Care providers. MPS Connect has a broad range of pharmaceutical supply agreements with aged care facilities and community pharmacies through existing business agreements and its parent company Sigma Healthcare.
MPS Connect Head of Healthcare Operations Renee Watson said:
“We are delighted to integrate the PainChek solution into MediSphere™, creating an integrated pain assessment and medication management solution for our home-based consumers. We are already a major supplier of pain medication in Australia and this collaboration further elevates our offering to that of a total pain management solution. Our initial target clients are the home care providers, but we see opportunities to extend the partnership into broader home consumer markets in line with the increasing demand for home care.”
, developer of the world’s first smart phone-based pain assessment and monitoring application, is pleased to announce that is has entered the Australian Home Care market, establishing an integrated pain management solution with MPS Connect, a leading Australian medication services company.
